| Literature DB >> 32810435 |
Yifei Miao1, Lei Tian2, Marcy Martin3, Sharon L Paige4, Francisco X Galdos4, Jibiao Li5, Alyssa Klein3, Hao Zhang2, Ning Ma2, Yuning Wei6, Maria Stewart7, Soah Lee4, Jan-Renier Moonen3, Bing Zhang8, Paul Grossfeld9, Seema Mital10, David Chitayat11, Joseph C Wu2, Marlene Rabinovitch3, Timothy J Nelson12, Shuyi Nie5, Sean M Wu4, Mingxia Gu13.
Abstract
Hypoplastic left heart syndrome (HLHS) is a complex congenital heart disease characterized by abnormalities in the left ventricle, associated valves, and ascending aorta. Studies have shown intrinsic myocardial defects but do not sufficiently explain developmental defects in the endocardial-derived cardiac valve, septum, and vasculature. Here, we identify a developmentally impaired endocardial population in HLHS through single-cell RNA profiling of hiPSC-derived endocardium and human fetal heart tissue with an underdeveloped left ventricle. Intrinsic endocardial defects contribute to abnormal endothelial-to-mesenchymal transition, NOTCH signaling, and extracellular matrix organization, key factors in valve formation. Endocardial abnormalities cause reduced cardiomyocyte proliferation and maturation by disrupting fibronectin-integrin signaling, consistent with recently described de novo HLHS mutations associated with abnormal endocardial gene and fibronectin regulation. Together, these results reveal a critical role for endocardium in HLHS etiology and provide a rationale for considering endocardial function in regenerative strategies.Entities:
Keywords: ETS1; NOTCH; de novo mutation; endocardium; endothelial to mesenchymal transition; fibronectin; human heart tissue; hypoplastic left heart syndrome; induced pluripotent stem cells; single-cell RNA-seq
Mesh:
Year: 2020 PMID: 32810435 PMCID: PMC7541479 DOI: 10.1016/j.stem.2020.07.015
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633